10th Annual International Conference on Pharmacy and Pharmaceutical Sciences
Academic member responsible for the conference
- Dr. Robert Sindelar, Head, Pharmaceutical Unit, ATINER & Professor and Dean Emeritus Faculty of Pharmaceutical Sciences, The University of British Columbia, Canada.
ATINER will accept remote (online) presentations of 15 (fifteen) minutes in cases that onsite presentations are not possible by the speaker. Please note that many attendees including those who present a paper may choose the online option. However, ATINER will provide full fledged services (lunches, dinners, excursions) even if one participant presents onsite.
The Pharmaceutical Unit of ATINER is organizing its 10th Annual International Conference on Pharmacy and Pharmaceutical Sciences, 1-4 May 2023, Athens, Greece sponsored by the Athens Journal of Health and Medical Sciences.
The aim of the conference is to bring together academics and researchers from all areas of pharmaceutical sciences and other related fields. Theoretical and empirical research papers will be considered. In previous conferences, discussions have included a wide range of topics, such as: Drug Discovery & Design, Drug Analysis, Drug Delivery, Novel Technologies & New Developments, Pharmacognosy, Pharmacology, Pharmaceutical Chemistry, Public Health & Pharmacy Practice, Cardiovascular Disease, Cancer, Diabetes, Infection and Transmitted Diseases, Nanomedicine & Nanobiotechnology, Obesity, Nutrition, History of Pharmacy and Medicine, Public Policy Issues, and the Economics of Drugs, etc. Consistent with the theme of ATINER’s small academic events, all programs may include a few sessions on current topics in education and research.
Please note that all our conferences are non-thematic as explained in our policy (click here). However, academic members and friends can take the lead to organize and chair a stream as part of this conference.
Please submit an abstract (email only) to: email@example.com, using the abstract submission form by 21 March 2023 to: Dr. Robert Sindelar, Head, Pharmaceutical Unit, ATINER & Professor and Dean Emeritus Faculty of Pharmaceutical Sciences, The University of British Columbia, Canada. Abstracts should include the following: Title of Paper, Full Name (s), Affiliation, Current Position, an email address, and at least 3 keywords that best describe the subject of your submission. Decisions are reached within 4 weeks.
If you want to participate without presenting a paper, i.e. organize a stream, chair a session, review papers to be included in the conference proceedings or books, contribute to the editing of a book, or any other contribution, please send an email to Dr. Gregory T. Papanikos, President, ATINER (firstname.lastname@example.org).